| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 蛋白质试剂(元) | 40,072,550.30 | 16,512,120.97 | 25,245,704.94 | 8,462,917.93 |
| 多肽合成试剂(元) | 442,066,064.90 | 221,348,086.46 | 354,121,700.27 | 183,206,840.43 |
| 通用型分子砌块(元) | 65,136,356.06 | 29,710,662.39 | 57,852,180.17 | 31,916,828.27 |
| 原料药、医药中间体等(元) | 45,948,837.96 | - | - | - |
| 其他(元) | 9,037,510.06 | 2,727,601.69 | 14,655,082.72 | 1,470,682.79 |
| 营业成本(元) | ||||
| 蛋白质试剂(元) | 27,065,575.04 | 11,116,220.94 | - | 5,211,140.49 |
| 多肽合成试剂(元) | 267,628,093.80 | 132,908,419.81 | 206,987,379.30 | 108,399,275.56 |
| 通用型分子砌块(元) | 38,434,933.66 | 16,717,077.71 | 37,082,755.02 | 20,762,160.85 |
| 原料药、医药中间体等(元) | 55,444,103.40 | - | - | - |
| 其他(元) | 3,937,864.81 | 564,899.91 | - | 308,691.32 |
| 毛利(元) | ||||
| 蛋白质试剂(元) | 13,006,975.26 | 5,395,900.03 | - | 3,251,777.44 |
| 多肽合成试剂(元) | 174,437,971.10 | 88,439,666.65 | 147,134,320.97 | 74,807,564.87 |
| 通用型分子砌块(元) | 26,701,422.40 | 12,993,584.68 | 20,769,425.15 | 11,154,667.42 |
| 原料药、医药中间体等(元) | -9,495,265.44 | - | - | - |
| 其他(元) | 5,099,645.25 | 2,162,701.78 | - | 1,161,991.47 |
| 毛利率(%) | ||||
| 蛋白质试剂(%) | 32.46 | 32.68 | - | 38.42 |
| 多肽合成试剂(%) | 39.46 | 39.96 | 41.55 | 40.83 |
| 通用型分子砌块(%) | 40.99 | 43.73 | 35.90 | 34.95 |
| 原料药、医药中间体等(%) | -20.66 | - | - | - |
| 其他(%) | 56.43 | 79.29 | - | 79.01 |
| 收入构成(%) | ||||
| 蛋白质试剂(%) | 6.65 | 6.11 | 5.59 | 3.76 |
| 多肽合成试剂(%) | 73.40 | 81.89 | 78.37 | 81.40 |
| 通用型分子砌块(%) | 10.82 | 10.99 | 12.80 | 14.18 |
| 原料药、医药中间体等(%) | 7.63 | - | - | - |
| 其他(%) | 1.50 | 1.01 | 3.24 | 0.65 |
| 毛利构成(%) | ||||
| 蛋白质试剂(%) | 6.20 | 4.95 | 0.00 | 3.60 |
| 多肽合成试剂(%) | 83.16 | 81.14 | 87.63 | 82.77 |
| 通用型分子砌块(%) | 12.73 | 11.92 | 12.37 | 12.34 |
| 原料药、医药中间体等(%) | -4.53 | - | - | - |
| 其他(%) | 2.43 | 1.98 | 0.00 | 1.29 |